BridgeBio Pharma (BBIO) Divestments (2021 - 2025)

BridgeBio Pharma has disclosed Divestments across 3 years of filings, most recently posting $2.3 million for Q3 2025.

• Divestments for Q3 2025 came in at $2.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (down 91.04% YoY), and the FY2025 annual result was $2.3 million, down 91.04% from the prior year.
• Divestments came in at $2.3 million for Q3 2025 at BridgeBio Pharma, down from $25.7 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $29.4 million in Q4 2021 to a low of $2.3 million in Q3 2025.
• The 3-year median for Divestments is $25.7 million (2024), against an average of $19.1 million.